Want to join the conversation?
Drugstore chain $WBA reported a decline in 3Q16 earnings due to fluctuations in the quarterly fair value adjustments of AmerisourceBergen warrants. Net income fell to $1.1Bil or $1.01 per share from $1.3Bil or $1.18 per share last year. Net sales grew to $29.5Bil from $28.8Bil. Non-GAAP EPS increased to $1.18 from $1.02.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?